New Commercial Leadership: Kirk Stockwood Joins Octave – Read More 

About

On a mission to power the art of medicine with scientific insights to change the paradigm of care in MS

Every MS patient is unique. Knowing when and how to best treat them is the greatest challenge to solve.

At Octave, we deliver comprehensive insights that bring scientific clarity to MS, enabling an optimal care journey for patients to live more harmonious lives.

Every MS patient is unique. Knowing when and how to best treat them is the greatest challenge to solve.

At Octave, we deliver comprehensive insights that bring scientific clarity to MS, enabling an optimal care journey for patients to live more harmonious lives.

Our principles reflect our purpose.

Inquisitive Empathy

We care deeply about the patient experience—and are always open to hearing how we can improve it.

Scientific Innovation

In combination with science, we build solutions using technology, AI, and machine learning that power the art of medicine for MS providers.

Comprehensive Insights

We use rigorous scientific discipline to generate novel data and insights that address unmet needs in MS care.

Continuous Learning

The journey never ends. Based on new discoveries, we have built a foundation that allows us to learn and apply our knowledge together.

Our Leadership Team

A visionary and experienced team focused on the mission to provide precision care for MS patients.

Doug Biehn

President, Chief Executive Officer

Marcel Konrad

Chief Financial Officer

Debbie Ledet

Chief Access Officer

Ferhan Qureshi

Senior Vice President, Biomarker R&D

Kirk Stockwood

Senior Vice President, Commercial

Terrie Livingston

Vice President, Medical Affairs

Erika B. Ortiz

Director of People Operations

Jennifer Graves, MD, PhD, MAS

Senior Medical Director

Darin Okuda, MD

Senior Medical Advisor
Loading...

Board of Directors

Octave is backed by seasoned and passionate healthcare leaders.

William Hagstrom

Chairman of the Board

Doug Biehn

President and CEO, Octave

Brook Byers

Kleiner Perkins Caufield & Byers

Tom Hawes

Managing Director, Healthcare, Sandbox Industries

Grant Heidrich III

Independent Venture Capital & Private Equity Professional

Lucy Coassin

Northpond Ventures

Michael Pellini

Foundation Medicine, Section 32

George Scangos

Former CEO Vir, Biogen, Exelixis
Loading...

Our Investors

byers
merckv3
valhalla
drx cap